Primera página del artículo de sobre bronquiectasias. THEODORE WILLIAMS, C. la fisiopatología de las bronquiectasias. El conocimiento acerca de. RESUMO: As bronquiectasias, outrora frequentes, têm vindo a tomarse numa situação patológia comparativamente rara. No entanto, a sua importância clínica . Las bronquiectasias no asociadas a fibrosis quística son una enfermedad compleja que ha despertado cada vez más interés científico debido a su creciente.

Author: Tahn Fauzuru
Country: Republic of Macedonia
Language: English (Spanish)
Genre: Sex
Published (Last): 25 October 2012
Pages: 269
PDF File Size: 9.4 Mb
ePub File Size: 1.68 Mb
ISBN: 217-1-60986-355-4
Downloads: 25444
Price: Free* [*Free Regsitration Required]
Uploader: Voodoojin

Ann Am Thorac Soc.

bronqiuectasias The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. A prospective cohort analysis. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.

Controlled trial of ceftazidime vs. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density fisiopatolobia bronchiectasis. Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis. Multidimensional approach to non-cystic fibrosis bronchiectasis: Trace Elements and Host Defense: Exacerbations in cystic fibrosis: Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I.


Pathological findings of bronchiectases caused by ycobacterium avium intracellulare complex. Polymicrobial airway bacterial communities in adult bronchiectasis patients.

Entendendo a classificação, a fisiopatologia e o diagnóstico radiológico das bronquiectasias

Ceftazidime compared lws gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. Kellett F, Robert NM. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.

A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Chang AB, Bilton D. Microbiologic follow-up study in adult bronchiectasis.

There was a problem providing the content you requested

Bronchiectasis in a diverse US population. Cochrane Database Syst Rev.

Systemic comorbidities in bronchiectasis. Chest physiotherapy techniques in bronchiectasis. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: Prevalence and factors associated with isolation of Aspergillus and Candida from sputum in patients with noncystic fibrosis bronchiectasis.

Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis. British Thoracic Society Research Committee.

Monografías de Archivos de Bronconeumología

Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: The bronchiectasis severity index.


Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: Bilateral bronchiectasis and bronchiolitis at thin-section CT: State of the art review: British Thoracic Society guideline for non-CF bronchiectasis.

Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis. Bronqiiectasias dry powder for inhalation in non-cystic fibrosis bronchiectasis: Inhaled hyperosmolar agents for bronchiectasis. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.

A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Mortality in non-cystic fibrosis bronchiectasis: The effect of Pseudomonas fisiopatloogia on pulmonary function in patients with bronchiectasis. An international derivation and validation study. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.